Bunitrolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263114This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F2613LO055, chemically known as 2-propanol, 3-(tert-butylamino)-1-(m-cyanophenoxy)- but generally known as bunitrolol, which bears US NIH Compound Identifier 2473. Bunitrolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bunitrolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05978MIG. The term BUNITROLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). BUNITROLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bunitrolol under HS 29269095 and SITC 51484. As of Q4 2014, BUNITROLOL remains the US FDA Preferred Term for this commodity. Bunitrolol bears US NLM identifiers UMLS ID C0006387 and NCI Concept Code C72614. SMILES: OC(CNC(C)(C)C)COC1C(CCCC1)C#N.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.